Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statement of Stockholders' Deficit

v3.21.1
Consolidated Statement of Stockholders' Deficit - USD ($)
Preferred Stock
Common Stock
Common Shares Issuable
Additional Paid-in Capital
Accumulated Deficit
Noncontrolling Interest
Total
Beginning balance, shares at Dec. 31, 2019 2,449,778 69,784,699 0        
Beginning balance, amount at Dec. 31, 2019 $ 3,000,000 $ 70,000,000 $ 0 $ 548,118,000 $ (567,332,000) $ (169,000) $ (19,310,000)
Issuance of common stock upon conversion of notes payable, shares   814,734          
Issuance of common stock upon conversion of notes payable, amount   $ 1,000   162,000     163,000
Net loss         (1,708,000)   (1,708,000)
Ending balance, shares at Mar. 31, 2020 2,449,778 70,599,433 0        
Ending balance, amount at Mar. 31, 2020 $ 3,000 $ 71,000 $ 0 548,280,000 (569,040,000) (169,000) (20,855,000)
Beginning balance, shares at Dec. 31, 2020 2,449,778 5,218,122          
Beginning balance, amount at Dec. 31, 2020 $ 3,000 $ 5,000 $ 0 566,356,000 (595,628,000) (169,000) (29,433,000)
Extinguishment of debt upon adoption of ASU 2020-06       (4,745,000) 226,000   (4,519,000)
Conversion of Preferred Series J to common stock, shares (2,353,548) 692,220          
Conversion of Preferred Series J to common stock, amount $ (2,000) $ 1,000   1,000     0
Issuance of common stock upon conversion of notes payable, shares   3,779,322 7,634,000        
Issuance of common stock upon conversion of notes payable, amount   $ 4,000 $ 25,956,000 12,846,000     38,806,000
Common shares issued upon exercise of warrants, shares   94,824          
Common shares issued upon exercise of warrants, amount   $ 0   58,000     58,000
Issuance of common stock in public offering, net of costs, shares   4,945,000          
Issuance of common stock in public offering, net of costs, amount   $ 5,000   24,674,000     24,679,000
Issuance of common stock for research and development agreement, shares   189,753          
Issuance of common stock for research and development agreement, amount   $ 0   1,355,000     1,355,000
Issuance of common stock for services, shares   1,957,374          
Issuance of common stock for services, amount   $ 2,000   8,450,000     8,452,000
Issuance of common stock for compensation, shares   3,640,816          
Issuance of common stock for compensation, amount   $ 4,000   14,292,000     14,296,000
Net loss         (29,677,000)   (29,677,000)
Ending balance, shares at Mar. 31, 2021 96,230 20,517,431          
Ending balance, amount at Mar. 31, 2021 $ 1,000 $ 21,000 $ 25,956,000 $ 623,287,000 $ (625,079,000) $ (169,000) $ 24,017,000